# FDA Inspection 817363 - OLAX Corp. - February 04, 2013

Source: https://www.keypedia.com/records/fda_inspections/olax-corp/41aaaaf7-16ea-4546-85d7-7076c54e2a8e
Source feed: FDA_Inspections

> FDA Inspection 817363 for OLAX Corp. on February 04, 2013. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 817363
- Company Name: OLAX Corp.
- Inspection Date: 2013-02-04
- Classification: Official Action Indicated (OAI)
- Project Area: Unapproved and Misbranded Drugs
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1229287 - 2025-12-09](https://www.keypedia.com/records/fda_inspections/olax-corp/6f40d270-5892-44ee-9a16-3cf00386e693)
- [FDA Inspection 1229287 - 2025-12-09](https://www.keypedia.com/records/fda_inspections/olax-corp/146e9076-f78f-4e06-acff-c4e035ea8e70)
- [FDA Inspection 1020028 - 2017-08-01](https://www.keypedia.com/records/fda_inspections/olax-corp/747aebc0-9683-4bdd-ae45-9e6a024f6384)
- [FDA Inspection 858675 - 2013-12-10](https://www.keypedia.com/records/fda_inspections/olax-corp/e49b7bbc-2bde-4452-8e87-ac93363ce95c)
- [FDA Inspection 817363 - 2013-02-04](https://www.keypedia.com/records/fda_inspections/olax-corp/24a20af0-2bd8-41d3-9873-5805909a48eb)

Company: https://www.keypedia.com/companies/olax-corp/9738ed69-058f-42ea-bfef-d8890ea297b1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c